Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot®) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison
- Author
- DIENER, Hans-Christoph1 ; JANSEN, Jan-Peter2 ; RECHES, Avinoan3 ; PASCUAL, Julio4 ; PITEI, Daniela5 ; STEINER, Timothy J6
[1] Department of Neurology, University of Essen, Berlin, Germany
[2] Schwerpunktpraxis Schmerztherapie, Berlin, Germany
[3] Department of Neurology, Hadassah University Hospital, Jerusalem, Israel
[4] Service of Neurology, University Hospital Marqués de Valdecilla, Santander, Spain
[5] Pfizer Central Research, Sandwich, United Kingdom
[6] Division of Neuroscience, Imperial College School of Medicine, London, United Kingdom
Eletriptan and Cafergot® Comparative Study Group - Source
European neurology. 2002, Vol 47, Num 2, pp 99-107 ; ref : 22 ref
- Publisher
- Karger, Basel
- Publication country
- Switzerland
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adulte Agoniste Antimigraineux Association médicamenteuse Bloquant α-adrénergique Caféine Chimiothérapie Douleur Elétriptan Ergot dérivé Ergotamine Etude comparative Migraine Pronostic Récepteur sérotoninergique Stimulant SNC Stimulant sérotoninergique Toxicité Traitement Vasoconstricteur Voie orale Appareil circulatoire pathologie Cérébrovasculaire pathologie Encéphale pathologie Homme Système nerveux central pathologie Système nerveux pathologie Vaisseau sanguin pathologie
- Keyword (en)
- Adult Agonist Antimigrainous agent Drug combination Alpha blocking agent Caffeine Chemotherapy Pain Eletriptan Ergot derivatives Ergotamine Comparative study Migraine Prognosis Serotonine receptor CNS stimulant Serotonin agonist Toxicity Treatment Vasoconstrictor agent Oral administration Cardiovascular disease Cerebrovascular disease Cerebral disorder Human Central nervous system disease Nervous system diseases Vascular disease
- Keyword (es)
- Adulto Agonista Agente antimigrañoso Asociación medicamentosa Bloqueador α-adrenérgico Cafeína Quimioterapia Dolor Eletriptán Ergot derivado Ergotamina Estudio comparativo Jaqueca Pronóstico Receptor serotoninérgico Estimulante SNC Estimulante serotoninérgico Toxicidad Tratamiento Vasoconstrictor Vía oral Aparato circulatorio patología Vaso sanguíneo encéfalo patología Encéfalo patología Hombre Sistema nervosio central patología Sistema nervioso patología Vaso sanguíneo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F04 Vasodilator agents. Cerebral vasodilators
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 13499758
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1159/000047960 
https://dx.doi.org/10.1159/000047960
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000047960\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:9:\"\u0000*\u0000jtitle\";s:18:\"European neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Eur. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"107\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-3022\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DIENER\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Hans-Christoph\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:17:\"JANSEN, Jan-Peter\";i:1;s:15:\"RECHES, Avinoan\";i:2;s:14:\"PASCUAL, Julio\";i:3;s:14:\"PITEI, Daniela\";i:4;s:18:\"STEINER, Timothy J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EUNEAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000047960\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:9:\"\u0000*\u0000jtitle\";s:18:\"European neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Eur. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"107\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-3022\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DIENER\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Hans-Christoph\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:17:\"JANSEN, Jan-Peter\";i:1;s:15:\"RECHES, Avinoan\";i:2;s:14:\"PASCUAL, Julio\";i:3;s:14:\"PITEI, Daniela\";i:4;s:18:\"STEINER, Timothy J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EUNEAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000047960\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000047960\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:9:\"\u0000*\u0000jtitle\";s:18:\"European neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Eur. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"107\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-3022\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DIENER\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Hans-Christoph\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:17:\"JANSEN, Jan-Peter\";i:1;s:15:\"RECHES, Avinoan\";i:2;s:14:\"PASCUAL, Julio\";i:3;s:14:\"PITEI, Daniela\";i:4;s:18:\"STEINER, Timothy J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EUNEAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000047960\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:9:\"\u0000*\u0000jtitle\";s:18:\"European neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Eur. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"107\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-3022\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DIENER\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Hans-Christoph\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:17:\"JANSEN, Jan-Peter\";i:1;s:15:\"RECHES, Avinoan\";i:2;s:14:\"PASCUAL, Julio\";i:3;s:14:\"PITEI, Daniela\";i:4;s:18:\"STEINER, Timothy J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EUNEAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:17:\"10.1159\/000047960\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:9:\"\u0000*\u0000jtitle\";s:18:\"European neurology\";s:9:\"\u0000*\u0000stitle\";s:11:\"Eur. neurol\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"47\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:2:\"99\";s:8:\"\u0000*\u0000epage\";s:3:\"107\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-3022\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DIENER\";s:10:\"\u0000*\u0000aufirst\";s:14:\"Hans-Christoph\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:17:\"JANSEN, Jan-Peter\";i:1;s:15:\"RECHES, Avinoan\";i:2;s:14:\"PASCUAL, Julio\";i:3;s:14:\"PITEI, Daniela\";i:4;s:18:\"STEINER, Timothy J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EUNEAP\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:201:\"Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot\u00ae) in the acute treatment of migraine: A multicentre, randomised, double-blind, placebo-controlled comparison\";s:8:\"\u0000*\u0000place\";s:5:\"Basel\";s:6:\"\u0000*\u0000pub\";s:6:\"Karger\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
